Literature DB >> 7891629

A performance study of the Loma Linda proton medical accelerator.

G Coutrakon1, J Hubbard, J Johanning, G Maudsley, T Slaton, P Morton.   

Abstract

More than three years have passed since Loma Linda treated the first cancer patient with the world's first proton accelerator dedicated to radiation therapy. Since that time, over 1000 patients have completed treatments and the facility currently treats more than 45 patients per day. With a typical intensity of 3 x 10(10) protons per pulse and 27 pulses per minute, dose rates of 90-100 cGy/min are easily achieved on a 20-cm diameter field. In most cases, patient treatment times are 2 min, much less than the patient alignment time required before each treatment. Nevertheless, there is considerable medical interest in increasing field sizes up to 40-cm diameter while keeping dose rates high and treatment times low. In this article, beam measurements relevant to intensity studies are presented and possible accelerator modifications for upgrades are proposed. It is shown that nearly all intensity losses can be ascribed to the large momentum spread of the injected beam and occur at or near the injection energy of 2 MeV. The agreement between calculations and measurements appears quite good. In addition, optimum beam characteristics for a new injector are discussed based upon the momentum acceptance and space charge limits of the Loma Linda synchrotron.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891629     DOI: 10.1118/1.597270

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  8 in total

1.  Tracker Readout ASIC for Proton Computed Tomography Data Acquisition.

Authors:  Robert P Johnson; Joel Dewitt; Cole Holcomb; Scott Macafee; Hartmut F-W Sadrozinski; David Steinberg
Journal:  IEEE Trans Nucl Sci       Date:  2013-10       Impact factor: 1.679

2.  Normal liver tissue change after proton beam therapy.

Authors:  Nobuyoshi Fukumitsu; Shinsei Takahashi; Toshiyuki Okumura; Toshiki Ishida; Keiko Nemoto Murofushi; Kayoko Ohnishi; Teruhito Aihara; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai
Journal:  Jpn J Radiol       Date:  2018-07-06       Impact factor: 2.374

3.  A systematic review of publications on charged particle therapy for hepatocellular carcinoma.

Authors:  Hiroshi Igaki; Masashi Mizumoto; Toshiyuki Okumura; Kiyoshi Hasegawa; Norihiro Kokudo; Hideyuki Sakurai
Journal:  Int J Clin Oncol       Date:  2017-09-04       Impact factor: 3.402

Review 4.  Proton therapy - Present and future.

Authors:  Radhe Mohan; David Grosshans
Journal:  Adv Drug Deliv Rev       Date:  2016-12-03       Impact factor: 15.470

5.  A Review of Proton Therapy - Current Status and Future Directions.

Authors:  Radhe Mohan
Journal:  Precis Radiat Oncol       Date:  2022-04-27

6.  A Fast Experimental Scanner for Proton CT: Technical Performance and First Experience with Phantom Scans.

Authors:  Robert P Johnson; Vladimir Bashkirov; Langley DeWitt; Valentina Giacometti; Robert F Hurley; Pierluigi Piersimoni; Tia E Plautz; Hartmut F-W Sadrozinski; Keith Schubert; Reinhard Schulte; Blake Schultze; Andriy Zatserklyaniy
Journal:  IEEE Trans Nucl Sci       Date:  2015-12-10       Impact factor: 1.679

7.  Simulation study of dosimetric effect in proton beam therapy using concomitant boost technique for unresectable pancreatic cancers.

Authors:  Nobuyoshi Fukumitsu; Toshiyuki Okumura; Yuichi Hiroshima; Toshiki Ishida; Haruko Numajiri; Keiko Nemoto Murofushi; Kayoko Ohnishi; Teruhito Aihara; Hitoshi Ishikawa; Koji Tsuboi; Hideyuki Sakurai
Journal:  Jpn J Radiol       Date:  2018-05-10       Impact factor: 2.374

8.  Software platform for simulation of a prototype proton CT scanner.

Authors:  Valentina Giacometti; Vladimir A Bashkirov; Pierluigi Piersimoni; Susanna Guatelli; Tia E Plautz; Hartmut F-W Sadrozinski; Robert P Johnson; Andriy Zatserklyaniy; Thomas Tessonnier; Katia Parodi; Anatoly B Rosenfeld; Reinhard W Schulte
Journal:  Med Phys       Date:  2017-03       Impact factor: 4.506

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.